NCT02096705 - Phase III Insulin Add-On Asia Regional Program - ST | Biotech Hunter

Enrollment

477

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

January 28, 2016

Study Completion Date

January 28, 2016

Conditions

Diabetes

Interventions

DRUG

Dapagliflozin

Tablet

DRUG

Dapagliflozin Placebo

Tablet

Trial Locations (29)

35233

Local Institution, Daejeon

42415

Local Institution, Daegu

49241

Local Institution, Busan

100029

Local Institution, Beijing

100039

Local Institution, Beijing

100700

Local Institution, Beijing

100730

Local Institution, Beijing

130041

Local Institution, Changchun

150001

Local Institution, Haerbin

169856

Local Institution, Singapore

200040

Local Institution, Shanghai

200072

Local Institution, Shanghai

200080

Local Institution, Shanghai

200092

Local Institution, Shanghai

210012

Local Institution, Nanjing

214023

Local Institution, Wuxi

215004

Local Institution, Suzhou

400010

Local Institution, Chongqing

410000

Local Institution, Changsha

410008

Local Institution, Changsha

510080

Local Institution, Guangzhou

510120

Local Institution, Guangzhou

529889

Local Institution, Singapore

610072

Local Institution, Chengdu

710032

Local Institution, Xi’an

710061

Local Institution, Xi’an

Unknown

Local Institution, Tianjin

06351

Local Institution, Seoul

134-727

Local Institution, Seoul